FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2769375533> ?p ?o ?g. }

• W2769375533 abstract "Hypertension is the leading cause of end-stage renal disease, and one of the goals of anti-hypertensive treatment is to protect the kidney. However, it is unknown how low of blood pressure as the treatment target should be so that anti-hypertensive therapy would not bring harm to patients especially for those already suffer from chronic kidney disease (CKD). Thus, we used the data set from The Systolic Blood Pressure Intervention Trial (SPRINT) to study the effect of lowering systolic blood pressure on renal disease development. The SPRINT data randomly assigned patients with a systolic blood pressure (SBP) of 130 mm Hg or higher to a SBP treatment target of less than 120 mm Hg (intensive treatment, n=4678) or a treatment target of less than 140 mm Hg (standard treatment, n=4683). We examined the effect of intensive treatment on six renal outcomes: 1) CKD composite, 2)50 percent reduction in eGFR, 3) dialysis 4) albuminuria, 5) 30 percent reduction in eGFR for patients with CKD at baseline (n=2646) and 6) albuminuria for patients without CKD at baseline (n=6715). Generalized Estimating Equation is used to account the correlation of blood pressure levels over time. At the end of year 1, the mean SBP was 121.4± 0.21 mm Hg in the intensive treatment group and 136.2± 0.21 mm Hg in the standard treatment group. The patients in intensive group were found to have a higher chance of 30% reduction of eGFR (OR=3.684, 95% CI= 2.51-5.40) than in standard treatment group. There was no difference between intensive and standard treatment groups for other 5 outcomes. In addition, 1 mm Hg elevation in SBP in patients with CDK at baseline significantly increased the chance of CKD composite (OR=1.03, 95% CI=1.01-1.04), the chance of 50 percent reduction in eGFR (OR=1.02, 95% CI=1.01-1.05), and chance of 30 percent reduction in eGFR (OR=1.02, 95% CI=1.01-1.02). Thus, SBP significantly correlated with renal outcomes in CKD patients. Our data show that five renal outcomes examined using SPRINT data set are not improved by intensive management of SBP in CKD patients, rather, patients received intensive management have a higher risk of eGFR reduction by 30%, which could be detrimental. Our study indicated that intensive SBP management should not be recommended to CKD patients." @default.
• W2769375533 created "2017-12-04" @default.
• W2769375533 creator A5019110366 @default.
• W2769375533 creator A5050487837 @default.
• W2769375533 date "2017-09-01" @default.
• W2769375533 modified "2023-09-26" @default.
• W2769375533 title "Abstract 113: Beneficial or Harmful? The Role of Intensive Anti-hypertensive Treatment in the Development of Chronic Kidney Disease" @default.
• W2769375533 doi "https://doi.org/10.1161/hyp.70.suppl_1.113" @default.
• W2769375533 hasPublicationYear "2017" @default.
• W2769375533 type Work @default.
• W2769375533 sameAs 2769375533 @default.
• W2769375533 citedByCount "0" @default.
• W2769375533 crossrefType "journal-article" @default.
• W2769375533 hasAuthorship W2769375533A5019110366 @default.
• W2769375533 hasAuthorship W2769375533A5050487837 @default.
• W2769375533 hasConcept C126322002 @default.
• W2769375533 hasConcept C126894567 @default.
• W2769375533 hasConcept C159641895 @default.
• W2769375533 hasConcept C164705383 @default.
• W2769375533 hasConcept C2776174234 @default.
• W2769375533 hasConcept C2778653478 @default.
• W2769375533 hasConcept C2779978075 @default.
• W2769375533 hasConcept C71924100 @default.
• W2769375533 hasConcept C84393581 @default.
• W2769375533 hasConceptScore W2769375533C126322002 @default.
• W2769375533 hasConceptScore W2769375533C126894567 @default.
• W2769375533 hasConceptScore W2769375533C159641895 @default.
• W2769375533 hasConceptScore W2769375533C164705383 @default.
• W2769375533 hasConceptScore W2769375533C2776174234 @default.
• W2769375533 hasConceptScore W2769375533C2778653478 @default.
• W2769375533 hasConceptScore W2769375533C2779978075 @default.
• W2769375533 hasConceptScore W2769375533C71924100 @default.
• W2769375533 hasConceptScore W2769375533C84393581 @default.
• W2769375533 hasIssue "suppl_1" @default.
• W2769375533 hasLocation W27693755331 @default.
• W2769375533 hasOpenAccess W2769375533 @default.
• W2769375533 hasPrimaryLocation W27693755331 @default.
• W2769375533 hasRelatedWork W1526922141 @default.
• W2769375533 hasRelatedWork W1718902802 @default.
• W2769375533 hasRelatedWork W179950642 @default.
• W2769375533 hasRelatedWork W2018794681 @default.
• W2769375533 hasRelatedWork W2032037433 @default.
• W2769375533 hasRelatedWork W2067005179 @default.
• W2769375533 hasRelatedWork W2112939271 @default.
• W2769375533 hasRelatedWork W2113464500 @default.
• W2769375533 hasRelatedWork W2115339068 @default.
• W2769375533 hasRelatedWork W2415666679 @default.
• W2769375533 hasRelatedWork W2430441395 @default.
• W2769375533 hasRelatedWork W2578251537 @default.
• W2769375533 hasRelatedWork W2791342410 @default.
• W2769375533 hasRelatedWork W2887085595 @default.
• W2769375533 hasRelatedWork W3014329149 @default.
• W2769375533 hasRelatedWork W3145886289 @default.
• W2769375533 hasRelatedWork W47120740 @default.
• W2769375533 hasRelatedWork W938779276 @default.
• W2769375533 hasRelatedWork W167946213 @default.
• W2769375533 hasRelatedWork W2183503591 @default.
• W2769375533 hasVolume "70" @default.
• W2769375533 isParatext "false" @default.
• W2769375533 isRetracted "false" @default.
• W2769375533 magId "2769375533" @default.
• W2769375533 workType "article" @default.